Twice- or once-daily dosing of novel oral anticoagulants for stroke prevention: a fixed-effects meta-analysis with predefined heterogeneity quality criteria
about
Choosing Non-Vitamin K Antagonist Oral Anticoagulants: Practical Considerations We Need to KnowNon-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis.Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users.
P2860
Twice- or once-daily dosing of novel oral anticoagulants for stroke prevention: a fixed-effects meta-analysis with predefined heterogeneity quality criteria
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Twice- or once-daily dosing of ...... heterogeneity quality criteria
@ast
Twice- or once-daily dosing of ...... heterogeneity quality criteria
@en
Twice- or once-daily dosing of ...... heterogeneity quality criteria
@nl
type
label
Twice- or once-daily dosing of ...... heterogeneity quality criteria
@ast
Twice- or once-daily dosing of ...... heterogeneity quality criteria
@en
Twice- or once-daily dosing of ...... heterogeneity quality criteria
@nl
prefLabel
Twice- or once-daily dosing of ...... heterogeneity quality criteria
@ast
Twice- or once-daily dosing of ...... heterogeneity quality criteria
@en
Twice- or once-daily dosing of ...... heterogeneity quality criteria
@nl
P2860
P1433
P1476
Twice- or once-daily dosing of ...... heterogeneity quality criteria
@en
P2093
Andreas Clemens
Martina Brueckmann
P2860
P304
P356
10.1371/JOURNAL.PONE.0099276
P407
P577
2014-01-01T00:00:00Z